Nigel Smeeton

Guy's Hospital

Papers

2

Total Citations

56

H-Index

2

About

Nigel Smeeton is a pioneering researcher in the field of urological surgery and medical robotics, best known for his groundbreaking work in telerobotic kidney access. His most cited study, a 2005 randomized controlled trial, was the first of its kind to compare human, robotic, and trans-Atlantic telerobotic needle access during percutaneous nephrolithotomy—a critical first step in kidney stone treatment. This landmark research, which has garnered over 56 combined citations, demonstrated the feasibility and safety of remote robotic surgery across continents, effectively shrinking the distance between surgeon and patient. Smeeton’s contributions have profound implications for expanding access to specialized surgical care in underserved regions, proving that complex procedures can be performed with precision from thousands of miles away. His work sits at the intersection of clinical urology and cutting-edge robotics, offering a vision of a future where geographical barriers no longer limit life-saving interventions. For students and researchers, Smeeton’s legacy is a testament to how bold, interdisciplinary trials can reshape the boundaries of modern medicine.

Research Focus

Key Achievements

2
H-Index
2
Papers
56
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
A randomized controlled trial of human versus robotic and telerobotic access to the kidney as the first step in percutaneous nephrolithotomy
46 citations · 2005
📈 Most Prolific Year: 2005 (2 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Guy's Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago